Indeed, APP/PS1 transgenic AD mice treated with PAW showed improved memory function and reduced amyloid burden, potentially via anti-inflammatory and anti-oxidative effects, compared to age-matched wild-type controls [255,256]. This evidence concerns the gene APP and Alzheimer disease.